20Slash20 Inc., the company behind The Eye Drink, announced it will participate in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, scheduled for Sept. 9–10, 2026, in New York City. CEO Dr. Roger Wu is set to deliver an investor presentation on Sept. 9 at 9:35 a.m. ET at The Westin New York Grand Central, followed by one-on-one meetings with investors.
The conference brings together growth companies, investors, and industry professionals across life sciences and emerging sectors, providing a platform for 20Slash20 to showcase its innovative product. The Eye Drink is described as the world’s first ready-to-drink functional beverage formulated with science-backed ingredients to support eye health for individuals who spend extended periods on phones and computers. This addresses a growing concern in today’s screen-centric world, where prolonged digital device use has been linked to eye strain and other vision-related issues.
The announcement underscores the increasing relevance of functional beverages targeting specific health needs. As screen time continues to rise globally, products like The Eye Drink offer a convenient solution for consumers seeking proactive measures to protect their vision. The company’s participation in this investor conference signals its intent to attract investment and expand its market presence, potentially impacting the broader wellness and beverage industries.
For investors, this presentation offers an opportunity to learn about 20Slash20’s business model, growth strategy, and the scientific foundation of its product. The conference format, which includes one-on-one meetings, allows for in-depth discussions with company leadership, making it a significant event for those interested in the health and wellness sector.
The full press release can be viewed at https://ibn.fm/tm2lT. 20Slash20’s participation in this event highlights its commitment to raising awareness about eye health and its ambition to become a leader in the functional beverage market. As the company prepares to present, industry observers will be watching to see how it positions The Eye Drink in a competitive landscape that includes other health-focused beverages.
Moody Capital Solutions’ conference is designed to connect innovative companies with investors, and 20Slash20’s inclusion suggests that its product has captured attention as a potential disruptor. The company’s focus on eye health, a niche not yet fully explored in the beverage industry, could set it apart and open new market opportunities.
For more information about 20Slash20 and The Eye Drink, interested parties can refer to the full press release. The conference is expected to provide valuable exposure for the company as it seeks to expand its reach and establish itself as a key player in the wellness sector.
